tiprankstipranks
Protagonist Therapeutics reports two-year follow up data from REVIVE study
PremiumThe FlyProtagonist Therapeutics reports two-year follow up data from REVIVE study
5M ago
Protagenic Therapeutics reports two-year follow up data from REVIVE study
PremiumThe Fly
Protagenic Therapeutics reports two-year follow up data from REVIVE study
5M ago
Protagenic Therapeutics initiates Phase I/IIa trial for PT00114
PremiumThe Fly
Protagenic Therapeutics initiates Phase I/IIa trial for PT00114
7M ago
Protagenic Therapeutics to effect 1-for-4 reverse stock split
PremiumThe FlyProtagenic Therapeutics to effect 1-for-4 reverse stock split
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100